Canadian Study of Longevity in Type-1 Diabetes
Living with type 1 diabetes for 50 years or longer is a remarkable achievement. Dr. Bruce Perkins and his team are curious about lifestyle and intricacy of managing this complex disease over many years.
New Onset Type 1 Diabetes
Know someone who has developed type-1 diabetes in the last six months? If so Dr. James Shapiro and Dr. Peter Senior is recruiting for a study to reset the immune system and mobilize stem cells.
Viacyte's VC-02 Beta-Cell Replacement
Bringing 'stem cell therapy' to the clinic, Dr. James Shapiro and Dr. Peter Senior are recruiting volunteers with T1D to study the use of Viacyte's pancreatic endoderm cells PEC-01 (VC-02) in clinic.
Polyclonal Regulatory T cell (PolyTreg) Immunotherapy in Islet Transplantation
Testing the efficacy of Polyclonal Regulatory T cells (PolyTregs) in immune protection of transplant grafts in clinical islet transplantation.
Relamorelin in Patients with Diabetic Gastroparesis
Gastroparesis (DG) is a disorder causing vomiting, nausea, abdonimal pain, bloating, and post prandial fullness and early satiety. Researchers are testing a new medication to treat DG caused by diabetes.
Expect: Long Acting Insulin Degludec in Pregnant Women with Type 1 Diabetes
Researchers are investigating whether a new long acting insulin is safe and effective for use in pregnancy.
Young adults and their food choices
McGill University's School of Human Nutrition is investigating food literacy in young adults with type 1 diabetes and potential barriers young adults face in integrating nutrition knowledge into their lifestyle. Recruitment poster here